<!DOCTYPE html>
<html lang="en">
    <head>
        <meta name="DC.IDENTIFIER" content="http://dx.doi.org/10.17917/V9AP-D094" scheme="DCTERMS.UI"><title>caNanoLab DOI Landing page</title>
        <style>
            h1 { text-align: center;}
            h2 { text-align: left;}
            table { border: 1px solid #dddddd; text-align: left; padding: 8px }
            td, th { border: 1px solid #dddddd; text-align: left; padding: 8px }
            tr:nth-child(even) { background-color: #dddddd }
        </style>
    </head><body><img src="./assets/images/crdc-logo.svg" alt="CRDC General Commons Logo"><h1> caNanoLab DOI </h1><hr><p><b>Protocol Type:</b> in vitro assay</p><p><b>Protocol Name:</b> NCL Method ITA-1: Analysis of Hemolytic Properties of Nanoparticles</p><p><b>Protocol Abbreviation:</b> ITA-1</p><p><b>Protocol Version:</b> 4<hr><p><b>DOI:</b> <a href = http://dx.doi.org/10.17917/V9AP-D094>http://dx.doi.org/10.17917/V9AP-D094</a></p><p><b>Protocol File:</b> protocols/20240410_18-57-43-564_NCL_Method_ITA-1.pdf<p><b>File Title:</b> ITA-1</p><p><b>Description:</b></b> This document describes a protocol for quantitative colorimetric determination of total hemoglobin in whole blood (TBH) and plasma free hemoglobin (PFH). An increase in the plasma free hemoglobin is indicative of erythrocyte damage by the test material (a positive control substance or a nanoparticle).<hr><p><b>Resource Type:</b>  Protocol</p><p><b>Data Access:</b> <a href =https://general.datacommons.cancer.gov/#/data>https://general.datacommons.cancer.gov/#/data</a><p></body></html>